Items with tag "cardiovascular diseases"

News

CRISPR eliminates heart disease in embryos

American and South Korean scientists have successfully removed a part of the genome of human embryos using CRISPR-Cas9 to eradicate a hereditary heart disease, according to a study published in Na…

Read more

TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction

TiGenix, stem cell specialist focused on developing novel therapeutics from its two proprietary platforms of donor-derived expanded adipose derived stem cells (eASC) and donor-derived expanded car…

Read more

Celyad's cardiac stem cell treatment fails phase III clinical trials

Celyad’s cardiac therapy C-Cure® failed to show a significant benefit in the CHART-1 phase III clinical study. C-Cure is an experimental treatment based on stem cells that produce new autologous h…

Read more

Novo Nordisk’s diabetes drug also lowers heart risks

Since Eli Lilly and Boehringer Ingelheim demonstrated that their diabetes pill Jardiance lowers the risk of cardiovascular complications, competitors such as Merck, Pfizer and Novo Nordisk have be…

Read more

Insights

New laser-based medical device revolutionizes cardiovascular disease diagnosis

New laser-based medical device revolutionizes cardiovascular disease diagnosis

Imec and Ghent University have developed a unique photonic-based medical device for the screening of arterial stiffness and the diagnosis of cardiovascular diseases. The brainchild of researchers …

Read more

Reinforcing veins with computer simulations

Reinforcing veins with computer simulations

Each year, more than two million patients worldwide undergo a procedure called coronary artery bypass grafting (CABG). CABG is used to treat blocked arteries and restore normal blood flow to the h…

Read more

Self-expanding stents to treat the silent killer: aneurysm

Self-expanding stents to treat the silent killer: aneurysm

The continuous flow in jet-induced fountains inspired Nourredine Frid, CEO at Cardiatis (Isnes), to apply the theory of fluid mechanics to blood vessels. By converting turbulence to laminar flow i…

Read more

World’s first regenerative product for heart failure

World’s first regenerative product for heart failure

Celyad developed a breakthrough Cardiopoiesis platform designed to differentiate stem cells into cardiac cells to treat heart failure and acute myocardial infarction. The lead product, C-Cure® is …

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

Biowin UGent Turnstone V-Bio Ventures Flanders.bio GSK KU Leuven XpandInnovation Itera Life Science Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.